Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.8K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
Local Anesthetics: Chemistry and Structure-Activity Relationship01:30

Local Anesthetics: Chemistry and Structure-Activity Relationship

6.7K
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
6.7K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

2.8K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.8K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

3.9K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

1.0K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.0K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

2.2K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-Guided Discovery of a Nonpeptidic MT5-MMP Inhibitor.

ACS medicinal chemistry letters·2026
Same author

Pharmacophore-driven kinase profiling applied to the PKIS2 chemogenomic dataset.

Scientific reports·2026
Same author

11<sup>th</sup> National Conference of the French Chemoinformatics Society (SFCi).

Molecular informatics·2026
Same author

Mapping ligands for MT<sub>1</sub>/MT<sub>2</sub> and 5-HT<sub>2C</sub> receptors: Chemotypes, SAR, and polypharmacology.

Drug discovery today·2026
Same author

Navigating pharmacophore space to identify activity discontinuities: A case study with BCR-ABL.

Molecular informatics·2024
Same author

Towards a partial order graph for interactive pharmacophore exploration: extraction of pharmacophores activity delta.

Journal of cheminformatics·2023

Related Experiment Video

Updated: Feb 12, 2026

3D Printing of Preclinical X-ray Computed Tomographic Data Sets
11:06

3D Printing of Preclinical X-ray Computed Tomographic Data Sets

Published on: March 22, 2013

41.1K

The Pharmacophore Network: A Computational Method for Exploring Structure-Activity Relationships from a Large

Jean-Philippe Métivier1,2, Bertrand Cuissart2, Ronan Bureau1

  • 1Centre d'Etudes et de Recherche sur le Médicament de Normandie , Normandie Univ, UNICAEN, CERMN , 14000 Caen , France.

Journal of Medicinal Chemistry
|April 13, 2018
PubMed
Summary

This study introduces a pharmacophore network for organizing large molecule datasets, enabling drug discovery tasks like analyzing chemical series relationships and compound activity. It facilitates large-scale structure-activity relationship (SAR) analysis and classification.

More Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.6K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.4K

Related Experiment Videos

Last Updated: Feb 12, 2026

3D Printing of Preclinical X-ray Computed Tomographic Data Sets
11:06

3D Printing of Preclinical X-ray Computed Tomographic Data Sets

Published on: March 22, 2013

41.1K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.6K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.4K

Area of Science:

  • Medicinal Chemistry
  • Cheminformatics
  • Computational Drug Discovery

Background:

  • Traditional structure-activity relationship (SAR) analysis is limited by small molecule sets.
  • Public databases like ChEMBL offer vast molecular data for analysis.
  • Organizing and analyzing large chemical datasets is crucial for modern drug discovery.

Purpose of the Study:

  • To introduce a novel pharmacophore network for organizing large molecule datasets.
  • To enable large-scale SAR analysis and facilitate drug discovery processes.
  • To demonstrate the utility of pharmacophore networks in classification tasks.

Main Methods:

  • Automatic discovery of pharmacophores from large molecular datasets.
  • Construction and navigation of a pharmacophore network.
  • Application of the network to BCR-ABL data for SAR analysis.
  • Benchmarking pharmacophore subsets for classification.

Main Results:

  • The pharmacophore network effectively organizes large chemical datasets.
  • Network navigation aids in studying chemical series relationships and activity influences.
  • The method successfully identified diverse binding modes and enabled large-scale SAR analysis.
  • Representative pharmacophore subsets proved effective for classification tasks.

Conclusions:

  • The pharmacophore network is a powerful tool for large-scale SAR analysis in drug discovery.
  • It facilitates understanding complex relationships within chemical series and compound activities.
  • Pharmacophore networks offer a scalable approach for data-driven drug design and classification.